MY119118A - Thiophenopyrimidines - Google Patents

Thiophenopyrimidines

Info

Publication number
MY119118A
MY119118A MYPI97000490A MYPI9700490A MY119118A MY 119118 A MY119118 A MY 119118A MY PI97000490 A MYPI97000490 A MY PI97000490A MY PI9700490 A MYPI9700490 A MY PI9700490A MY 119118 A MY119118 A MY 119118A
Authority
MY
Malaysia
Prior art keywords
6alkyl
formula
6alkyloxy
mono
substituted
Prior art date
Application number
MYPI97000490A
Other languages
English (en)
Inventor
Chen Chen
Thomas R Webb
James R Mccarthy
Terence J Moran
Original Assignee
Neurocrine Biosciences Inc
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurocrine Biosciences Inc, Janssen Pharmaceutica Nv filed Critical Neurocrine Biosciences Inc
Publication of MY119118A publication Critical patent/MY119118A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
MYPI97000490A 1996-02-07 1997-02-06 Thiophenopyrimidines MY119118A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1127496P 1996-02-07 1996-02-07
US2768996P 1996-10-08 1996-10-08

Publications (1)

Publication Number Publication Date
MY119118A true MY119118A (en) 2005-03-31

Family

ID=26682201

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI97000490A MY119118A (en) 1996-02-07 1997-02-06 Thiophenopyrimidines

Country Status (17)

Country Link
US (2) US6255310B1 (ja)
EP (1) EP0882051B1 (ja)
JP (1) JP2000504678A (ja)
KR (1) KR19990067390A (ja)
AR (1) AR005731A1 (ja)
AT (1) ATE208395T1 (ja)
CA (1) CA2233307A1 (ja)
DE (1) DE69708059T2 (ja)
DK (1) DK0882051T3 (ja)
ES (1) ES2167710T3 (ja)
ID (1) ID15904A (ja)
MY (1) MY119118A (ja)
NO (1) NO981356L (ja)
NZ (1) NZ330118A (ja)
PT (1) PT882051E (ja)
TW (1) TW448178B (ja)
WO (1) WO1997029110A1 (ja)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6191131B1 (en) 1997-07-23 2001-02-20 Dupont Pharmaceuticals Company Azolo triazines and pyrimidines
US6060478A (en) * 1996-07-24 2000-05-09 Dupont Pharmaceuticals Azolo triazines and pyrimidines
US6313124B1 (en) 1997-07-23 2001-11-06 Dupont Pharmaceuticals Company Tetrazine bicyclic compounds
US6124289A (en) * 1996-07-24 2000-09-26 Dupont Pharmaceuticals Co. Azolo triazines and pyrimidines
US7094782B1 (en) 1996-07-24 2006-08-22 Bristol-Myers Squibb Company Azolo triazines and pyrimidines
CN101328186A (zh) 1997-11-11 2008-12-24 辉瑞产品公司 用作抗癌药的噻吩并嘧啶和噻吩并吡啶衍生物
US6187777B1 (en) 1998-02-06 2001-02-13 Amgen Inc. Compounds and methods which modulate feeding behavior and related diseases
DE19837387A1 (de) * 1998-08-18 2000-02-24 Aventis Res & Tech Gmbh & Co 3'-Desoxypentopyranosyl-Nucleinsäure, ihre Herstellung und Verwendung
US6432989B1 (en) 1999-08-27 2002-08-13 Pfizer Inc Use of CRF antagonists to treat circadian rhythm disorders
EA200200424A1 (ru) 1999-09-30 2002-12-26 Ньюроджен Корпорейшн Некоторые гетероциклы, замещенные алкилендиамином
IL139197A0 (en) * 1999-10-29 2001-11-25 Pfizer Prod Inc Use of corticotropin releasing factor antagonists and related compositions
TWI271406B (en) 1999-12-13 2007-01-21 Eisai Co Ltd Tricyclic condensed heterocyclic compounds, preparation method of the same and pharmaceuticals comprising the same
EP1287001B1 (en) 2000-06-06 2004-09-29 Pfizer Products Inc. Thiophene derivatives useful as anticancer agents
US6503914B1 (en) * 2000-10-23 2003-01-07 Board Of Regents, The University Of Texas System Thienopyrimidine-based inhibitors of the Src family
TWI312347B (en) 2001-02-08 2009-07-21 Eisai R&D Man Co Ltd Bicyclic nitrogen-containing condensed ring compounds
KR100876622B1 (ko) 2001-04-27 2008-12-31 에자이 알앤드디 매니지먼트 가부시키가이샤 피라졸로[1,5-ａ]피리딘 화합물 및 그 의약
US7285557B2 (en) * 2001-10-15 2007-10-23 Smithkline Beecham P.L.C. Pyrimidinones as melanin concentrating hormone receptor 1
US6872827B2 (en) 2002-04-26 2005-03-29 Chembridge Research Laboratories, Inc. Somatostatin analogue compounds
US20100189797A1 (en) 2002-06-10 2010-07-29 Julien Mendlewicz Oral antidepressant formulation
US7671047B2 (en) * 2002-06-19 2010-03-02 Sanofi-Aventis Deutschland Gmbh Cationically substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use
US7176216B2 (en) 2002-10-22 2007-02-13 Eisai Co., Ltd. 7-phenylpyrazolopyridine compounds
ATE426600T1 (de) 2002-10-22 2009-04-15 Eisai R&D Man Co Ltd 7-phenylpyrazolopyridinverbindungen
US20060071832A1 (en) * 2002-10-29 2006-04-06 Zvi Regev Instantaneous phase digitizer
US20050001673A1 (en) * 2002-10-29 2005-01-06 Zvi Regev Direct digital frequency modulation / phase modulation decoder
US20060024661A1 (en) * 2003-07-30 2006-02-02 The Regents Of The University Of California Modulation of CRF potentiation of NMDA receptor currents via CRF receptor 2
CA2552503C (en) 2004-01-06 2011-09-13 Taisho Pharmaceutical Co., Ltd. Pyrrolopyrimidine and pyrrolotriazine derivatives
CN1910190A (zh) * 2004-01-06 2007-02-07 大正制药株式会社 环氨基取代的噻吩并嘧啶和噻吩并吡啶衍生物
CA2560742A1 (en) 2004-03-23 2005-10-06 Biogen Idec Ma Inc. Receptor coupling agents and therapeutic uses thereof
EP2527446A1 (en) 2004-06-03 2012-11-28 Athlomics Pty Ltd Agents and methods for diagnosing stress
JP2007161585A (ja) 2004-06-25 2007-06-28 Taisho Pharmaceut Co Ltd 環状アミノ基で置換されているピロロピリミジン及びピロロピリジン誘導体
WO2006050161A2 (en) 2004-10-29 2006-05-11 Biocryst Pharmaceuticals, Inc. Therapeutic furopyrimidines and thienopyrimidines
WO2006104945A2 (en) 2005-03-29 2006-10-05 Biocryst Pharmaceuticals, Inc. Hepatitis c therapies
WO2008082839A2 (en) * 2006-12-29 2008-07-10 Abbott Laboratories Pim kinase inhibitors as cancer chemotherapeutics
ES2396126T3 (es) 2008-04-15 2013-02-19 Eisai R&D Management Co., Ltd. Compuesto de 3-fenilpirazol[5,1-b]tiazol
AR078521A1 (es) 2009-10-08 2011-11-16 Eisai R&D Man Co Ltd Compuesto pirazolotiazol
US10984514B2 (en) 2015-09-18 2021-04-20 Nec Corporation Fingerprint capture system, fingerprint capture device, image processing apparatus, fingerprint capture method, and storage medium
CA3008171A1 (en) 2015-12-22 2017-06-29 SHY Therapeutics LLC Compounds for the treatment of cancer and inflammatory disease
IL310023A (en) 2017-06-21 2024-03-01 SHY Therapeutics LLC Compounds interacting with the RAS superfamily for the treatment of cancer, inflammation, RAS pathology and fibrotic diseases
CN110590807B (zh) * 2019-10-09 2022-01-07 陕西理工大学 一种噻吩并[3,2-d]嘧啶类衍生物及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2121950A1 (en) * 1971-05-04 1972-11-23 Dr. Karl Thomae Gmbh, 7950 Biberach Thieno(3,2-d)pyrimidine derivs - with thrombocyte aggregation inhibiting activity
EP0071227B1 (en) 1981-07-31 1987-11-11 Sloan-Kettering Institute For Cancer Research Anti-leukemic beta-glycosyl c-nucleosides
US5063245A (en) * 1990-03-28 1991-11-05 Nova Pharmaceutical Corporation Corticotropin-releasing factor antagonism compounds
CA2039411A1 (en) * 1990-03-30 1991-10-01 Ronnie Gerald Edie Thienopyrimidine derivatives
TW444018B (en) 1992-12-17 2001-07-01 Pfizer Pyrazolopyrimidines
DK0674641T3 (da) 1992-12-17 1999-09-27 Pfizer Pyrrolopyrimidiner som CRF-antagonister
TW530047B (en) * 1994-06-08 2003-05-01 Pfizer Corticotropin releasing factor antagonists
AU716993B2 (en) * 1995-05-12 2000-03-16 Neurogen Corporation Novel deazapurine derivatives; a new class of CRF1 specific ligands

Also Published As

Publication number Publication date
US6469166B2 (en) 2002-10-22
DE69708059D1 (en) 2001-12-13
ATE208395T1 (de) 2001-11-15
DE69708059T2 (de) 2002-07-18
DK0882051T3 (da) 2002-02-25
JP2000504678A (ja) 2000-04-18
EP0882051A1 (en) 1998-12-09
NO981356D0 (no) 1998-03-25
NO981356L (no) 1998-07-09
ES2167710T3 (es) 2002-05-16
AU1720997A (en) 1997-08-28
AU725674B2 (en) 2000-10-19
PT882051E (pt) 2002-04-29
US6255310B1 (en) 2001-07-03
WO1997029110A1 (en) 1997-08-14
US20020052362A1 (en) 2002-05-02
AR005731A1 (es) 1999-07-14
NZ330118A (en) 2000-03-27
ID15904A (id) 1997-08-14
TW448178B (en) 2001-08-01
CA2233307A1 (en) 1997-08-14
EP0882051B1 (en) 2001-11-07
KR19990067390A (ko) 1999-08-16

Similar Documents

Publication Publication Date Title
MY119118A (en) Thiophenopyrimidines
CA2233285A1 (en) Pyrazolopyrimidines as crf receptor antagonists
CA2272291A1 (en) Crf antagonistic quino- and quinazolines
CA2282890A1 (en) Therapeutic heterocyclic compounds
ZA909901B (en) Peptide compounds,a process for preparation thereof and pharmaceutical composition comprising the same
EP0629622A4 (ja)
IE882869L (en) Benzimidazoline-2-oxo-1-carboxylic acid derivatives
WO2001009103A3 (en) Imidazole antiproliferative agents
MXPA04005990A (es) Derivados de 5,6-diaril-pirazina-2-amida como antagonistas de cb1.
ATE59644T1 (de) 5,6-dihydro-2-(substituiertes phenyl)-1,2,4triazin-3,5(2h,4h)-dione.
PH25859A (en) Composition for treatment of ischemic disorder
PE20001297A1 (es) Antibioticos cetolidos carbamato y carbazato
WO2000026224A3 (en) Novel macrolide antibiotics
NO924929L (no) Farmasoeytisk aktive benzoquinazolinforbindelser
MY113945A (en) Amino substituted pyrimidines and triazines
GR3036639T3 (en) 5-(4-subst.-piperidinyl-1)-3-aryl-pentanoic acid derivatives as tachykinin receptor antagonist
MX9702203A (es) Derivados de pirazolil-pirazol substituidos, procedimientos para su preparacion y su uso como agentes con accion herbicida.
DE60216610D1 (de) Verwendung von kondensierten Pyrazolverbindungen für die Herstellung eines Arzneimittels zur Behandlung von Bluthochdruck
WO1999057125A3 (en) Hygromycin a derivatives
IL148196A0 (en) Heterocyclic compounds and pharmaceutical compositions containing the same
CA2374643A1 (en) 1-trifluoromethyl-4-hydroxy-7-piperidinylaminomethylchroman derivatives as substance p antagonists
GB2358398B8 (en) Steroid compounds, a method for preparation thereof, pharmaceutical compositions containing the same and use thereof
CA2331261A1 (en) 2"-deoxy hygromycin derivatives
CA2352332A1 (en) Hygromycin a derivatives
WO2001004095A3 (de) α-α' -SUBSTITUIERTE N-ALKYL-3-ALKENYLBENZOYL-PYRAZOL-DERIVATE